Emergence and Rising Prevalence of Artemisinin Partial Resistance Marker Kelch13 P441L in a Low Malaria Transmission Setting in Southern Zambia.

Prevalence of Asymptomatic non-Falciparum and Falciparum Malaria in the 2014-15 Rwanda Demographic Health Survey.

Baseline characteristics for phase II of the Kinshasa Malaria Cohort Study: cohort profile.

Population genomics of Plasmodium ovale species in sub-Saharan Africa.

High-throughput genotyping of Plasmodium vivax in the Peruvian Amazon via molecular inversion probes.

Temporal genomics in Southern Zambia shows rising prevalence of Plasmodium falciparum mutations linked to delayed clearance after artemisinin-lumefantrine treatment.

Evidence of artemisinin partial resistance in northwestern Tanzania: clinical and molecular markers of resistance.

Application of a new highly multiplexed amplicon sequencing tool to evaluate Plasmodium falciparum antimalarial resistance and relatedness in individual and pooled samples from Dschang, Cameroon.

Interchromosomal segmental duplication drives translocation and loss of P. falciparum histidine-rich protein 3.

Prevalence of mutations associated with artemisinin partial resistance and sulfadoxine-pyrimethamine resistance in 13Â regions in Tanzania in 2021: a cross-sectional survey.

Population genomics of Plasmodium ovale species in sub-Saharan Africa.

Development of new real-time PCR assays for detection and species differentiation of Plasmodium ovale.

Population Genomics of Plasmodium malariae from Four African Countries.

Single cell transcriptional changes across the blood stages of artemisinin resistant K13(580Y) Plasmodium falciparum upon dihydroartemisinin exposure.

Clinical and genomic diversity of Treponema pallidum subspecies pallidum to inform vaccine research: an international, molecular epidemiology study.